Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Alpha Teknova, Inc. (TKNO)

$4.97 -4.42% NASDAQ: TKNO · 15-min delayed
  • HOLLISTER, California
  • Public · NASDAQ: TKNO
  • 158 employees
$244.5MMarket cap
$40.5MRevenue · FY2025
-$17.3MNet income
158Employees
TKNONASDAQ
2021IPO

About Alpha Teknova, Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$40.5M
Net income
-$17.3M
Total assets
$103.6M
Market cap
$244.5M
Gross margin
33.2%
Operating margin
-41.9%
Net margin
-42.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$40.5M
Cost of revenue
$27.1M
Gross profit
$13.4M
Operating expenses
$30.4M
Operating income
-$17.0M
Income tax
$58.0K
Net income
-$17.3M
EPS (basic)
$-0.32
EPS (diluted)
$-0.32

Balance sheet

Total assets
$103.6M
Current assets
$34.5M
Total liabilities
$34.8M
Current liabilities
$7.5M
Shareholders’ equity
$68.8M

Cash flow

Operating cash flow
-$8.6M
Investing cash flow
$10.7M
Financing cash flow
$151.0K
Net cash flow
$2.2M

Statements via Polygon.io (SEC filings)

NASDAQ: TKNO
$4.97 -4.42%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.99 $6.37

52-week range

Market cap
$244.5M
EPS (diluted)
$-0.32
Shares outstanding
49.2M
Open
Day range
Prev close
Volume
IPO date
Jun 25, 2021

Alpha Teknova, Inc. (TKNO) Stock Price

  • Reported a net loss of $17.3M in FY2025.
  • Revenue grew 10% from FY2021 to FY2025.
  • Gross margin of 33.2%, net margin -42.6%.
  • Trading 22% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Alpha Teknova, Inc..

Write a review
Newsroom

News about Alpha Teknova, Inc.

News & sentiment via Polygon.io

FAQ

Alpha Teknova, Inc.: frequently asked questions

Is Alpha Teknova, Inc. an American company?

Alpha Teknova, Inc. is a US-based company headquartered in Hollister, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Alpha Teknova, Inc. headquartered?

Alpha Teknova, Inc. is headquartered in Hollister, California, United States.

Is Alpha Teknova, Inc. publicly traded?

Yes — Alpha Teknova, Inc. is a publicly traded company. Its stock trades under the ticker symbol TKNO on the NASDAQ.

What does Alpha Teknova, Inc. do?

Alpha Teknova, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →